S&P 500   3,855.36 (+0.36%)
DOW   30,960.00 (-0.12%)
QQQ   328.00 (+0.79%)
AAPL   143.26 (+3.01%)
MSFT   229.53 (+1.58%)
FB   277.57 (+1.12%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,289.87 (-0.07%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.29 (+1.62%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.93 (-1.46%)
GILD   68.16 (+1.82%)
S&P 500   3,855.36 (+0.36%)
DOW   30,960.00 (-0.12%)
QQQ   328.00 (+0.79%)
AAPL   143.26 (+3.01%)
MSFT   229.53 (+1.58%)
FB   277.57 (+1.12%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,289.87 (-0.07%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.29 (+1.62%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.93 (-1.46%)
GILD   68.16 (+1.82%)
S&P 500   3,855.36 (+0.36%)
DOW   30,960.00 (-0.12%)
QQQ   328.00 (+0.79%)
AAPL   143.26 (+3.01%)
MSFT   229.53 (+1.58%)
FB   277.57 (+1.12%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,289.87 (-0.07%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.29 (+1.62%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.93 (-1.46%)
GILD   68.16 (+1.82%)
S&P 500   3,855.36 (+0.36%)
DOW   30,960.00 (-0.12%)
QQQ   328.00 (+0.79%)
AAPL   143.26 (+3.01%)
MSFT   229.53 (+1.58%)
FB   277.57 (+1.12%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,289.87 (-0.07%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.29 (+1.62%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.93 (-1.46%)
GILD   68.16 (+1.82%)
Log in
FRA:SY1

Symrise AG (SY1.F) Stock Forecast, Price & News

€101.15
-0.15 (-0.15 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
€99.92
Now: €101.15
€101.15
50-Day Range
€100.30
MA: €105.79
€109.90
52-Week Range
€56.96
Now: €101.15
€73.48
Volume266,487 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Symrise AG develops, produces, and supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances. This segment's products are used by manufacturer of perfumes, personal care and cosmetic products, cleaning products, detergents, air fresheners, and oral care products. The Flavor segment provides flavors and functional ingredients used in the production of foods, beverages, and health products. The Nutrition segments offers tailored solutions for use in foods, beverages, pet foods, aquacultures, and cosmetics. This segment also provides preclinical screening services for skin, sebaceous glands, and hair. The company has a development partnership with c-LEcta for the development of an enzymatic process for the production of a flavoring agent. It operates in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. Symrise AG was founded in 1874 and is headquartered in Holzminden, Germany.
Symrise AG (SY1.F) logo

MarketRank

Overall MarketRank

0.78 out of 5 stars

Analyst Opinion: 2.1Community Rank: 1.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+49-5531-900
Employees10,413
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
€101.15
-0.15 (-0.15 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SY1 News and Ratings via Email

Sign-up to receive the latest news and ratings for SY1 and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Symrise AG (SY1.F) (FRA:SY1) Frequently Asked Questions

How has Symrise AG (SY1.F)'s stock price been impacted by Coronavirus?

Symrise AG (SY1.F)'s stock was trading at €89.38 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SY1 stock has increased by 13.2% and is now trading at €101.15.
View which stocks have been most impacted by COVID-19
.

Is Symrise AG (SY1.F) a buy right now?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Symrise AG (SY1.F) in the last year. There are currently 3 sell ratings, 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Symrise AG (SY1.F) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SY1, but not buy additional shares or sell existing shares.
View analyst ratings for Symrise AG (SY1.F)
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Symrise AG (SY1.F)?

Wall Street analysts have given Symrise AG (SY1.F) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Symrise AG (SY1.F) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for SY1?

15 Wall Street analysts have issued 1 year price targets for Symrise AG (SY1.F)'s stock. Their forecasts range from €90.00 to €127.00. On average, they anticipate Symrise AG (SY1.F)'s share price to reach €109.40 in the next year. This suggests a possible upside of 8.2% from the stock's current price.
View analysts' price targets for Symrise AG (SY1.F)
or view Wall Street analyst' top-rated stocks.

Who are some of Symrise AG (SY1.F)'s key competitors?

What other stocks do shareholders of Symrise AG (SY1.F) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Symrise AG (SY1.F) investors own include Abbott Laboratories (ABT), Everest Re Group (RE), Ambev (ABEV), Allianz SE (ALV.F) (ALV), Applied Materials (AMAT), BASF SE (BAS.F) (BAS), BRF (BRFS), Daimler AG (DAI.F) (DAI), Givaudan (GVDNY) and iShares Nasdaq Biotechnology ETF (IBB).

Who are Symrise AG (SY1.F)'s key executives?

Symrise AG (SY1.F)'s management team includes the following people:
  • Dr. Heinz-Jürgen Bertram, CEO, Chairman of Exec. Board & Labour Director (Age 63, Pay $1.66M)
  • Mr. Olaf Klinger, CFO & Member of Exec. Board (Age 55, Pay $1.02M)
  • Mr. Achim Daub, Member of Exec. Board and Pres of Scent & Care Worldwide (Age 59, Pay $1.02M)
  • Mr. Heinrich Schaper, Pres of Flavor Division & Member of Exec. Board (Age 65, Pay $1.05M)
  • Dr. Jean-Yves Parisot, Pres of Nutrition & Member of Exec. Board (Age 57, Pay $1.29M)
  • Dr. Jürgen Nienhaus, Corp. VP of Operations
  • Mr. Tobias Erfurth, Head of Investor Relation
  • Mr. Roberto Ascoli, Sr. VP of New Bus. Devel. - Scent & Care Division
  • Ms. Béatrice Favre-Bulle, Sr. VP of Scent & Care
  • Gerd Lösing, VP of Quality Control Global & Member of Supervisory Board

What is Symrise AG (SY1.F)'s stock symbol?

Symrise AG (SY1.F) trades on the FRA under the ticker symbol "SY1."

What is Symrise AG (SY1.F)'s stock price today?

One share of SY1 stock can currently be purchased for approximately €101.15.

What is Symrise AG (SY1.F)'s official website?

The official website for Symrise AG (SY1.F) is www.symrise.com.

How can I contact Symrise AG (SY1.F)?

Symrise AG (SY1.F)'s mailing address is Muehlenfeldstrasse 1, HOLZMINDEN, 37603, Germany. The company can be reached via phone at +49-5531-900.

This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.